Trial NCT03379051

View at ClinicalTrials.gov 
Org. Study IDs: U2-VEN-109

Last trial update was posted on 2022-08-22

MeSH Interventions

Lenalidomide Venetoclax

MeSH Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Other Conditions

Chronic Lymphocytic Leukemia Non-Hodgkin Lymphoma

Stopping Reasons

Strategic/Business Decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID